BCV
CVS icon

Banque Cantonale Vaudoise’s CVS Health CVS Stock Holding History

Banque Cantonale Vaudoise’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.43M Buy
47,799
+19,925
+71% +$1.53M 0.13% 150
2025
Q4 		$2.21M Sell
27,874
-30,947
-53% -$2.44M 0.08% 245
2025
Q3 		$4.43M Buy
58,821
+35,755
+155% +$2.45M 0.17% 111
2025
Q2 		$1.59M Sell
23,066
-23,273
-50% -$1.53M 0.06% 283
2025
Q1 		$3.14M Buy
+46,339
New +$2.77M 0.14% 145
2024
Q3 		$2.3M Buy
36,545
+602
+2% +$35.1K 0.09% 219
2024
Q2 		$2.12M Buy
35,943
+20,602
+134% +$1.29M 0.08% 225
2024
Q1 		$1.22M Sell
15,341
-3,102
-17% -$237K 0.05% 322
2023
Q4 		$1.46M Sell
18,443
-15,842
-46% -$1.13M 0.06% 285
2023
Q3 		$2.39M Sell
34,285
-4,837
-12% -$343K 0.12% 139
2023
Q2 		$2.7M Sell
39,122
-969
-2% -$68.9K 0.13% 136
2023
Q1 		$2.98M Sell
40,091
-1,002
-2% -$84K 0.15% 133
2022
Q4 		$3.83M Sell
41,093
-6,295
-13% -$607K 0.2% 111
2022
Q3 		$4.52M Sell
47,388
-3,032
-6% -$300K 0.26% 70
2022
Q2 		$4.67M Sell
50,420
-9,083
-15% -$886K 0.24% 79
2022
Q1 		$6.02M Sell
59,503
-22,761
-28% -$2.39M 0.26% 73
2021
Q4 		$8.49M Buy
82,264
+4,387
+6% +$405K 0.33% 50
2021
Q3 		$6.61M Sell
77,877
-15,018
-16% -$1.26M 0.28% 63
2021
Q2 		$7.75M Buy
92,895
+41,644
+81% +$3.41M 0.34% 51
2021
Q1 		$3.86M Buy
51,251
+228
+0.4% +$16.6K 0.2% 108
2020
Q4 		$3.48M Sell
51,023
-6,309
-11% -$410K 0.19% 108
2020
Q3 		$3.35M Buy
57,332
+5,978
+12% +$372K 0.21% 99
2020
Q2 		$3.33M Buy
51,354
+3,950
+8% +$249K 0.24% 82
2020
Q1 		$2.81M Sell
47,404
-10,348
-18% -$691K 0.24% 87
2019
Q4 		$4.29M Buy
+57,752
New +$4.06M 0.29% 62

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Banque Cantonale Vaudoise's CVS Position: Q1 2026 in Review

Banque Cantonale Vaudoise increased its CVS Health (CVS) stake by 71% in Q1 2026, buying an estimated $1.53M and bringing the position to 47,799 shares worth $3.43M. The position accounts for 0.13% of the portfolio, ranked #150.

Banque Cantonale Vaudoise first reported a position in CVS in Q4 2019 and has held it in 25 quarters since. The position peaked at $8.49M in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Banque Cantonale Vaudoise held 47,799 shares of CVS Health worth $3.43M as of Q1 2026.
  • Banque Cantonale Vaudoise bought 19,925 CVS Health shares in Q1 2026, an estimated $1.53M.
  • CVS Health made up 0.13% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #150 holding.
  • Banque Cantonale Vaudoise first reported a position in CVS Health in Q4 2019 and has held it in 25 quarters since.
  • Banque Cantonale Vaudoise's CVS Health position peaked at $8.49M in Q4 2021.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.